BRIEF published on 08/20/2024 at 07:05, 2 years 2 months ago SKAN Group Reaches Its Targets in the First Half of 2024 Profitability Net Sales Growth Order Intake Half-year Results SKAN Group
PRESS RELEASE published on 08/20/2024 at 07:00, 2 years 2 months ago SKAN Group reaches its targets in the first half of 2024 SKAN Group AG achieves targets with net sales growth of 17.2% and EBITDA increase of 15.7% in the first half of 2024. Strong order intake and backlog, confirming guidance for full year Net Sales Growth Order Intake EBITDA Increase Guidance SKAN Group
BRIEF published on 05/31/2024 at 07:05, 2 years 5 months ago SKAN Increases Stake in Aseptic Technologies to 90 Percent Pharmaceutical Industry Stake Increase SKAN Aseptic Technologies AT-Closed Vial®
PRESS RELEASE published on 05/31/2024 at 07:00, 2 years 5 months ago SKAN increases stake in Aseptic Technologies to 90 percent SKAN Group AG increases its stake in Aseptic Technologies to 90%, reinforcing strategic importance. Aseptic Technologies specializes in AT-Closed Vial® Technology for cell and gene therapy applications Pharmaceutical Industry Stake Increase SKAN Group AG Aseptic Technologies AT-Closed Vial® Technology
BRIEF published on 05/07/2024 at 18:05, 2 years 5 months ago SKAN Group AG's Annual General Meeting: Unanimous Approval of Proposals, Beat Lüthi Elected Chairman Annual General Meeting Shareholder Approval Dividend SKAN Group AG Chairman Election
PRESS RELEASE published on 05/07/2024 at 18:00, 2 years 5 months ago Annual General Meeting of SKAN Group AG approves all pro-posals and elects Beat Lüthi as Chairman SKAN AG Annual General Meeting approves all proposals and elects Beat Lüthi as Chairman. Distribution of CHF 0.35 dividend per share approved, next AGM on 5 May 2025 Board Of Directors Annual General Meeting Dividend Distribution SKAN AG Beat Lüthi
BRIEF published on 03/26/2024 at 07:05, 2 years 7 months ago SKAN Group Announces Strong Financial Performance in 2023 with Increased Sales and Margins Financial Performance EBITDA Margin Biopharmaceutical Industry Annual Report 2023 SKAN Group
PRESS RELEASE published on 03/26/2024 at 07:00, 2 years 7 months ago SKAN with higher sales and margin in 2023 SKAN Group AG achieved higher sales and margin in 2023, exceeding communicated financial targets. Strategic initiatives on track with positive outlook for 2024 2023 Strategic Initiatives SKAN Group AG Higher Sales Margin
PRESS RELEASE published on 08/22/2023 at 07:00, 3 years 2 months ago SKAN Group demonstrates operational strength
PRESS RELEASE published on 05/26/2023 at 17:45, 3 years 5 months ago SKAN Group AG informs about the ongoing investigation of the Office of the Attorney General of Switzerland
Published on 11/06/2026 at 22:15, 5 hours 58 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 15 hours 13 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 15 hours 43 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 15 hours 43 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 20:15, 7 hours 58 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 8 hours 57 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 9 hours 13 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 9 hours 40 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 10 hours 13 minutes ago ARVERNE GROUP: Number shares and voting rights
Published on 11/06/2026 at 18:00, 10 hours 13 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 10 hours 18 minutes ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 10 hours 38 minutes ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
